*Clearwire shareholders to vote on Sprint buyout May 21. NEW YORK, May 17- Minority shareholders of Clearwire Corp are expected to vote down a buyout offer from Sprint Nextel Corp next week and force the No.3 U.S. wireless company to cough up more cash for control of Clearwire's valuable spectrum.» Read More
CNBC's Scott Cohn reports on what the Justice Department calls the biggest health care fraud settlement in U.S. history; and CNBC's Seema Mody reports on the details of Bristol-Myers' plans to buy Amylin.
CNBC's David Faber reports the latest details on the takeover deal between German health care company Fresenius and Rhoen-Klinikum.
CNBC's Kayla Tausche reports Grupo Modelo has confirmed it is in talks on expanding its relationship with Anheuser-Busch.
Insight Venture Partners is currently working on a revision of its bid for Quest Software, reports CNBC's Kayla Tausche.
Campbell Dawson, Portfolio Manager, Elstree Investment Management advises investors go into defensives and fixed-income, adding that the euro debt crisis could drag on another 2 years.
Frank Sennett, "Groupon's Biggest Deal Ever" author, discusses Groupon's decision to decline Google's $6 billion bid back in 2010 and weighs in on the future of the deal-of-the-day company.
Four directors at Chesapeake Energy will resign from the company's board following discussions with Carl Icahn. CNBC's Kate Kelly has the details.
The FMHR traders share their top three trades of the hour, including shares of Avon moving higher on news it will consider Coty's takeover bid. Mark Mahaney, Citigroup internet analyst, also forecasts Groupon's earnings performance.
CNBC's David Faber reports Elliot International notified BMC Software it intends to nominate a slate of five board members and billionaire investor Carl Icahn is ready to disclose his stake in Chesapeake Energy.
The "Squawk on the Street" team discusses this morning's major headlines, including European stocks on the rebound, Coty's higher bid for Avon, and a new revelation from Facebook.
CNBC's Tyler Mathisen reports shares of P.F. Chang's are moving higher on news the Chinese food chain is being bought by Centerbridge Partners. Jeff Kilburg, Kilburg Capital, weighs in on other takeover targets.
CNBC's David Faber speaks to activist investor Carl Icahn regarding how much cash he has available to invest and whether Chesapeake Energy is undervalued.
Human Genome Sciences rejected the $2.6 billion unsolicited takeover bid from GlaxoSmithKline, reports CNBC's Herb Greenberg.
CNBC's Kayla Tausche reports on Illumina playing offense against Roche's hostile takeover bid, and the FMHR crew share their final trades of the hour.
CNBC's David Faber reports the latest details on Illumina's recommendation to shareholders to reject Roche's takeover offer.
Mad Money host Jim Cramer shares his final thoughts on the future of tech giants, Research in Motion and Yahoo.
The play on Research in Motion, and whether it's a prime takeover target, with the Fast Money crew.
Mad Money host Jim Cramer shares two things he thinks have to happen to save Avon: get rid of Jung, and ignore Coty's bid.
The Fast Money traders weigh in on how to play unusual options activity in Avon's shares on Monday.
CNBC's Brian Shactman breaks down today's big movers including two downgrades at Stifel Nicolaus, and Avon's rejection of a takeover bid from Coty.